These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

458 related items for PubMed ID: 26730754

  • 1. Stereotactic ablative body radiotherapy (SABR): an alternative to surgery in stage I-II non-small-cell cancer of the lung?
    Mirimanoff RO.
    Chin Clin Oncol; 2015 Dec; 4(4):42. PubMed ID: 26730754
    [Abstract] [Full Text] [Related]

  • 2. Is stereotactic ablative radiotherapy equivalent to sublobar resection in high-risk surgical patients with stage I non-small-cell lung cancer?
    Mahmood S, Bilal H, Faivre-Finn C, Shah R.
    Interact Cardiovasc Thorac Surg; 2013 Nov; 17(5):845-53. PubMed ID: 23900381
    [Abstract] [Full Text] [Related]

  • 3. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.
    Lagerwaard FJ, Verstegen NE, Haasbeek CJ, Slotman BJ, Paul MA, Smit EF, Senan S.
    Int J Radiat Oncol Biol Phys; 2012 May 01; 83(1):348-53. PubMed ID: 22104360
    [Abstract] [Full Text] [Related]

  • 4. Stereotactic Ablative Radiation Therapy for the Treatment of Early-stage Non-Small-Cell Lung Cancer: CEPO Review and Recommendations.
    Boily G, Filion É, Rakovich G, Kopek N, Tremblay L, Samson B, Goulet S, Roy I, Comité de l’évolution des pratiques en oncologie.
    J Thorac Oncol; 2015 Jun 01; 10(6):872-82. PubMed ID: 26001140
    [Abstract] [Full Text] [Related]

  • 5. Short report: interim safety results for a phase II trial measuring the integration of stereotactic ablative radiotherapy (SABR) plus surgery for early stage non-small cell lung cancer (MISSILE-NSCLC).
    Palma DA, Nguyen TK, Kwan K, Gaede S, Landis M, Malthaner R, Fortin D, Louie AV, Frechette E, Rodrigues GB, Yaremko B, Yu E, Dar AR, Lee TY, Gratton A, Warner A, Ward A, Inculet R.
    Radiat Oncol; 2017 Jan 27; 12(1):30. PubMed ID: 28129789
    [Abstract] [Full Text] [Related]

  • 6. Is radiofrequency ablation more effective than stereotactic ablative radiotherapy in patients with early stage medically inoperable non-small cell lung cancer?
    Bilal H, Mahmood S, Rajashanker B, Shah R.
    Interact Cardiovasc Thorac Surg; 2012 Aug 27; 15(2):258-65. PubMed ID: 22581864
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Patterns of Recurrence and Survival after Surgery or Stereotactic Radiotherapy for Early Stage NSCLC.
    van den Berg LL, Klinkenberg TJ, Groen HJM, Widder J.
    J Thorac Oncol; 2015 May 27; 10(5):826-831. PubMed ID: 25629639
    [Abstract] [Full Text] [Related]

  • 15. Outcomes of stereotactic ablative radiotherapy for central lung tumours: a systematic review.
    Senthi S, Haasbeek CJ, Slotman BJ, Senan S.
    Radiother Oncol; 2013 Mar 27; 106(3):276-82. PubMed ID: 23462705
    [Abstract] [Full Text] [Related]

  • 16. Forecasting the impact of stereotactic ablative radiotherapy for early-stage lung cancer on the thoracic surgery workforce.
    Edwards JP, Datta I, Hunt JD, Stefan K, Ball CG, Dixon E, Grondin SC.
    Eur J Cardiothorac Surg; 2016 Jun 27; 49(6):1599-606. PubMed ID: 26796110
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.